TAKP34 債券
以下是 TAKEDAPH DRN 公司債券的清單。投資者通常選擇公司債券,因為它們在市場波動時具有更高的穩定性。研究價格、收益率和其他統計數據並找到可靠的投資。
商品代碼 | YTM % | 成交量 | 價格 % | 票息 % | 到期日 | 未償金額 | 面值 | 最小面額金額 | 發行人 |
---|---|---|---|---|---|---|---|---|---|
7.35% | 2.23 M | 63.11% | 3.18% | 2050-07-09 | 2 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
7.25% | 500 K | 61.61% | 3.38% | 2060-07-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.74% | 5.36 M | 72.16% | 3.03% | 2040-07-09 | 1.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.36% | 817 K | 92.77% | 5.65% | 2054-07-05 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.35% | 1.22 M | 93.79% | 5.80% | 2064-07-05 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 6.34% | 4 K | 90.34% | 5.25% | 2045-06-23 | 500.41 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
6.07% | 14 K | 96.26% | 5.65% | 2044-07-05 | 800 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.40% | 2.95 M | 99.39% | 5.30% | 2034-07-05 | 1.1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.20% | 2.2 M | 87.76% | 2.05% | 2030-03-31 | 2.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 5.05% | 204 K | 99.89% | 4.00% | 2025-06-23 | 800.17 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
4.74% | 0 | 75.87% | 2.00% | 2040-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4.71% | 0 | 98.09% | 3.20% | 2026-09-23 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Shire Acquisitions Investments Ireland DAC |
4.66% | 30 K | 101.04% | 5.00% | 2028-11-26 | 1.73 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
3.59% | 0 | 87.38% | 1.38% | 2032-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.22% | 0 | 98.96% | 3.00% | 2030-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.01% | 0 | 92.60% | 1.00% | 2029-07-09 | 850 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.71% | 0 | 116.57% | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
2.69% | 0 | 96.08% | 0.75% | 2027-07-09 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.55% | 0 | 99.57% | 2.25% | 2026-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
— | — | — | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4.00% | 2025-06-23 | 303 K USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |